Risks

Qualy #53 - Screening for prostate cancer

Medications & supplements

Qualy #46 - Rapamycin’s effects on cancer, cardiovascular disease, and neurodegeneration

Medications & supplements

Guest Episode

David Light: Zantac recall due to cancer concerns – what you need to know

Ep. #75 with David Light
Risks

Qualy #24 - What are the “ABCs” of Alzheimer’s prevention?

Mental & Emotional Health

Qualy #16 - How much does cognitive activity ward off cognitive decline?

Risks

Free Article

Cortisol and cross-pollination

Risks

Guest Episode

Deep dive into cancer— History of oncology, novel approaches to treatment, and the exciting and hopeful future

Ep. #62 with Keith Flaherty, M.D.
Nutrition

Guest Episode

Fasting as a potent antidote to obesity, insulin resistance, type 2 diabetes, and the many symptoms of metabolic illness

Ep. #59 with Jason Fung, M.D.
Risks

Podcast Episode

Continuous glucose monitors - impact of food, sleep, and stress on glucose, the unmatched power of CGM to drive behavioral change, and the exciting future of CGM

Ep. #54 with Kevin Sayer: Chairman, President and Chief Executive Officer DexCom, Inc.
Risks

Guest Episode

A masterclass in cardiovascular disease and growth hormone - two topics that are surprising interrelated

Ep. #52 with Ethan Weiss, M.D.
Sleep

Guest Episode

Part I of III: Dangers of poor sleep, Alzheimer's risk, mental health, memory consolidation, and more

Ep. #47 with Matthew Walker Ph.D.
Risks

Free Article

Why am I such a knucklehead?

Risks

Guest Episode

How to thrive with type 1 diabetes and how everyone can benefit from the valuable insights

Ep. #41 with Jake Kushner, M.D.
Risks

Free Article

A radical new approach to Alzheimer’s?

Risks

Guest Episode

new frontiers in cancer therapy, medicine, and the writing process

Ep. #32 with Siddhartha Mukherjee, M.D., Ph.D.
Risks

Guest Episode

Part V of V: Lp(a), inflammation, oxLDL, remnants, and more

Ep. #24 with Thomas Dayspring, M.D., FACP, FNLA
Risks

Guest Episode

Part IV of V: statins, ezetimibe, PCSK9 inhibitors, niacin, cholesterol and the brain

Ep. #23 with Thomas Dayspring, M.D., FACP, FNLA
Risks

Guest Episode

Part III of V: HDL, reverse cholesterol transport, CETP inhibitors, and apolipoproteins

Ep. #22 with Thomas Dayspring, M.D., FACP, FNLA
Risks

Guest Episode

Part II of V: Lipid metrics, lipid measurements, and cholesterol regulation

Ep. #21 with Thomas Dayspring, M.D., FACP, FNLA
Risks

Guest Episode

Part I of V: an introduction to lipidology

Ep. #20 with Thomas Dayspring, M.D., FACP, FNLA
Risks

Narrative glossary: lipids

Risks

Guest Episode

stress testing the lipid energy model

Ep. #19 with Dave Feldman
Cholesterol

Transcript — The Drive — Dave Feldman

Risks

Free Article

Statins, Lp(a), and upcoming podcast guests